Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy

NCT01147757 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-12-06

No results posted yet for this study

Summary

Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.

Conditions

  • Pediatrics

Interventions

DRUG

remifentanil

During surgery, 3 different dose of remifentanil or placebo was infused.

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Jeong-Yeon Hong · Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01147757 on ClinicalTrials.gov